The role of cellular immunity in systemic vasculitis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed, 21 citations in OpenAlex.

1. Central nervous system vasculitis.Seminars in immunopathology · 2009
   Review
2. What you should know about PR3-ANCA. Evidence for the role of T cells in the pathogenesis of systemic vasculitis.Arthritis research · 2000
   Review
3. T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission.Clinical and experimental immunology · 1998
   Article

Corrections and comments

• Comment on
  Cell-mediated autoimmunity in patients with Wegener's granulomatosis (WG)1995

Authors and funding

2 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as